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RESUMO – Introdução: Estudos recentes têm apontado para um aumento da incidência de infecções por Chlamydia 
trachomatis (CT) e Neisseria gonorrhoeae (NG). Objetivos: Determinar a prevalência de infecção por CT e NG em 
utentes de uma consulta de Doenças de Transmissão Sexual (DST) num Hospital Universitário. Métodos: Foi realizado 
um estudo transversal nos utentes de uma clínica de DTS ao longo de um período de 10 anos. Os diagnósticos foram 
efectuados recorrendo a análise de amplificação de ácidos nucleicos (PCR). Resultados: Na população estudada houve 
um predomínio do sexo masculino (83,3%). A prevalência global da infecção por CT e NG foi de 1,6% e 0,8%, respec-
tivamente, e após implementação do rastreio a todos os utentes observados, a prevalência de infecção por CT subiu 
para 3%. Adicionalmente, 53% dos utentes assintomáticos foram diagnosticados como portares da infecção, 78% com 
infecção por CT e 22% com infecção por NG (p <0,05). O rastreio sistemático resultou no diagnóstico e no tratamento 
de uma média de 13,7 indivíduos assintomáticos. Conclusão: Contrariamente ao observado na infecção por NG, os 
autores encontraram um aumento da prevalência da infecção por CT, após implementação do rastreio sistemático de 
todos os utentes da consulta. A triagem para a infecção por CT possibilitou a identificação e tratamento das infecções 
assintomáticas por este microorganismo. Os autores sugerem o rastreio sistemático de todos os utentes das consultas de 
STD para a infecção por CT.
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CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE 
INFECTIONS IN ATTENDEES OF A SEXUALLY TRANSMITTED 
DISEASES CLINIC - A TEN YEAR TREND ANALYSIS
ABSTRACT – Background: Reports indicating incidence of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae 
(NG) infections have been increasing. Objectives: To determine the prevalence of CT and NG infected individuals 
attending a Sexually Transmitted Disease (STD) clinic in a University Hospital. Methods: A cross-sectional study was 
conducted on attendees of the STD clinic throughout a 10 year period. Diagnoses of CT and NG infections were 
enabled upon nucleic acid amplification analysis (PCR). Results: In our study population there was a male predomi-
nance (83.3%). Overall prevalence of CT and NG infection was 1.6% and 0.8%, respectively.  A prevalence of 3% of 
chlamydia infection was recorded when routine screening was implemented. More so, 53% of individuals displayed 
asymptomatic infection, 78% of which had chlamydia infection and 22% had gonococcal infection (p<0.05). Routine 
screening of STD attendees has resulted in the diagnosis and treatment of an average of 13.7 asymptomatic individuals. 
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Conclusion: Unlike gonococcal infection we found an increase of chlamydia infection prevalence when routine scree-
ning was implemented. Screening of STD attendees for CT provided the opportunity to identify and treat asymptomatic 
Chlamydia infections. Systematic screening of STD attendees of both genders for CT should be offered.
KEY-WORDS – Chlamydia Infections; Chlamydia trachomatis; Gonorrhea; Neisseria gonorrhoeae; Ambulatory Care 
Facilities.
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INTRODUCTION
Chlamydia trachomatis (CT) and Neisseria gonor-
rhoeae (NG) infections are the most frequent bacterial 
sexually transmitted diseases1 with increasing incidence 
as recently reported. In the United States, experts esti-
mate an annual incidence of 2.8 million new chlamydia 
infections and 720 000 new gonococcal infections, the 
majority of which are asymptomatic2. Thus, given the 
highly asymptomatic nature of the pathogen, the repor-
ted prevalence of genital chlamydia infections in the 
population is likely underestimated.
Chlamydia infection, and to a lower degree, gono-
coccal infection, are associated with some urogenital 
complications. In women, complications include pelvic 
inflammatory disease and ectopic pregnancy, whereas 
in men epididymitis, orchitis, prostatitis and proctitis 
have been described. Infertility and sexually acquired 
reactive arthritis (SARA) are known to occur in both 
gender as a consequence of these infections. Moreover, 
chlamydia and gonococcal infections increase 3- to 
6-fold the transmission or acquisition risk of human 
immunodeficiency virus (HIV)3.
The effectiveness of community based screening in 
reducing the incidence and consequences of CT  infec-
tion is well documented4. Nowadays, nearly every major 
U.S. public health organization recommends routine 
screening of sexually active young women for chlamydia 
infection5-7. There are no widely accepted guidelines for 
gonococcal infection screening8. 
DIAGNOSTIC TECHNIQUES
Nucleic acid amplification techniques (NAATs) such 
as polymerase chain reaction (PCR) are now widely 
available and are currently being used for diagnosis of 
genital chlamydia and gonococcal infections. Tests can 
be performed in urine, urethral, vaginal, rectal, con-
junctival or pharyngeal specimens and their superiority 
over other techniques has been demonstrated9. Recently 
however, new strains of CT have emerged (the Swedish 
variant), leading to false negative results since most 
commercially available NAATs fail to detect them. To 
overcome this, new real-time PCR assays for detection 
of CT have been developed10. 
In some European countries, there are no clear 
guidelines for screening these bacterial infections, and 
as such, screening programs differ among medical 
centres. Herein, we aimed to determine the prevalen-
ces and predictors of CT and NG infections among 
the attendees of the STD clinic in Hospital de S. Joao, 
Porto, throughout a 10 year period. More so, we set out 
to evaluate whether routine screening in both genders 
should be extended to other health institutions.
MATERIAL AND METHODS
We carried out a retrospective review of all medical 
records of STD clinic attendees diagnosed with microbio-
logical infections by NAATs, namely CT and NG. Several 
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variables were analysed, including age, gender, sexual 
behaviour, clinic manifestations, treatment and follow-up. 
COBAS® Amplicor (Roche, Basel, Switzerland) had 
been used for the diagnosis of CT and NG infections 
from 2001 through 2006 in every patient, and respective 
partner, suspected of having one of the infections. Ever 
since, artus 3000 TM® (Qiagen, Hamburg, Germany), a 
real-time PCR for CT detection and an ‘in house’ method 
for NG detection have been systematically performed to 
all STD attendees regardless of complaints. Since 2004, 
CT serovars are also being determined. The specimens 
collected include first-void urine, vaginal, urethral or 
rectal swabs.
Statistical analysis was performed using SPSS sof-
tware version 17.0 using the χ2 test. P values of <0.05 
were considered statistically significant.
RESULTS
Of the 2711 attendees throughout the 10 year study 
period, 60 had positive laboratory PCR results to either 
CT or NG infection; 39 were diagnosed with chlamydia 
infection (10 between 2001 and 2006 and 29 after 
2007), 21 with gonococcal infection (13 between 2001 
and 2006 and 8 after 2007). Additionally, co-infection 
by both microbial agents was observed in 4 patients.
The overall prevalence of CT and NG infections 
was 1.6% and 0.8% respectively. From 2007 onwards, 
routine screening of both infections in first-void urine 
was implemented and a prevalence of 3% and 0.8% 
were recorded for chlamydia infection and gonococcal 
infection, respectively.
Table 1 depicts the comparison of socio-demographic, 
behavioural characteristics and clinical data between the 
two groups of bacterial genital infection. We found a clear 
male predominance (83.3% of individuals) in our study 
population; five of them (8.3%) were emigrants, mainly 
from African countries, 3 of which were non-Caucasian.
As far as age is concerned, CT infections were more 
frequent around the 30ies, whereas two peaks were 
found for NG infection, one in the 20ies and another in 
the 50ies. However, no differences in median age were 
found.
Thirty-four patients (56.6%; 34/60) had completed 
primary school, while 26 (43%; 26/60) had high school or 
university graduation, however no differences were obser-
ved for either chlamydia or gonorrhoea group of patients.
Regular sex partner was predominantly reported, 
namely boy/girlfriend (38%; 23/60) or spouse (16%; 
10/60). However, in the gonorrhoea infected partici- 
pants there was a predominance in the married group 
over the occasional partners group, (p<0.05). The 
majority of participants (87%; 52/60) reported being 
heterosexual in both groups of bacterial infections. 
The most frequently reported symptoms were dis-
charge, dysuria and pruritus. Patients with gonorrhoea 
displayed symptoms more frequently than the chlamydia 
participants (67% vs 36%; p< 0.05). Dysuria, discharge 
and purulent discharge were more often reported by the 
attendees with gonorrhoea infection (p< 0.05). Pruritus, 
which was the least reported complaint, was equally dis-
tributed among the groups.
Individuals diagnosed with chlamydia infection were 
frequently more infected with other sexually transmitted 
infections (STI) than individuals with gonococcal infection 
(p< 0.05). Diagnosed co-infections were also distinct 
between groups. In chlamydia infection participants, 
genital warts were the most common co-infection ( 33%; 
13/39) followed by syphilis (15%; 6/39,). In contrast, 
the gonorrhoea group of participants displayed a pre-
dominance of chlamydia co-infection (4/21), followed 
by genital warts (2/21). Only 7% (4/60) of the attendees 
were co-infected with both chlamydia and gonorrhoea. 
Concurrent HIV infection was only found in attendees 
from the chlamydia infection group (8%; 3/39). 
All patients presented a negative urine cure test follo-
wing one month treatment and in none of them it was 
isolated Lymphogranuloma venereum serovar (L1-L3).
All patients diagnosed with chlamydia infection were 
prescribed azithromycine (1 g orally in a single dose) 
and all gonococcal infections where treated with ceftria-
xone (250 mg intramuscular in a single dose).
ASYMPTOMATIC CHLAMYDIA AND GONOR-
RHOEA INFECTIONS
Asymptomatic chlamydia and gonorrhoea infections 
were found in 53% (32/60) of individuals, 78% (25/39) 
of whom had CT infection and only 22% (7/21) NG 
infection (p<0.05). In five attendees, the diagnosis 
of asymptomatic genital infection was accomplished 
through partner notification.
Table 2 displays the differences between symptoma-
tic and asymptomatic individuals with genital chlamydia 
or gonococcal infection.
We found that asymptomatic STD attendees with 
chlamydia or gonococal infections were either married 
or live-in partners more frequently, and presented more 
concurrent STIs than symptomatic attendees (Table 2). 
There were no statistically significant differences between 
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the two groups of asymptomatic bacterial genital infec-
tion regarding socio-demographic and behavioural 
characteristics.
DISCUSSION
Prevalence and incidence of CT and NG infections 
can be variable, depending on the different settings 
in which the studies are performed. In a population 
based survey, Fenton et al11 reported an incidence of CT 
infection in female and male patients aged 18-44 years 
of 2.2% and 1.5%, respectively. These values appear 
higher when the study is restricted to the female gender, 
younger age and to particular medical environments, 
namely gynaecology or dermatology consultations. The 
scenario for gonorrhoea infection however is similar, 
with reported values from 0.2 to 1.5%12-13.
Table 1 - Comparison of socio-demographic and behavioural characteristics and clinical data between
C. trachomatis and N. gonorrhoeae infected patients
Chlamydia trachomatis Neisseria gonorrhoeae P Value*
n % n %
Male 31 79 18 86 NS
Age Median (years) 35 39
Marital status NS
Married / Live-in partner 11 28 7 33
Not married / No live-in partner 28 72 14 67
Education level NS
Primary school 23 59 11 52
Highschool/ University 16 41 10 48
Sexual orientation NS
Heterossexual 34 87 18 86
MSM 5 13 3 14
Number of partners in the previous 6 months
0 2 5 1 5
1 2 5 8 38
2 – 4 20 51 12 57
>4 15 39
Partner 0,03
Steady 24 62 8 38
Ocasional 15 38 13 62
Other STI 26 67 7 33 0,08
Symptoms Present 14 36 14 67 0,02
Discharge 14 36 14 67 0,02
Dysuria 7 18 8 38 0,04
Pruritus 6 15 1 5 NS
*= χ2 test; STI= Sexually Transmitted Infection; MSM= Men who have sex with Men; NS = Not significant
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In our study population, there was a male predomi-
nance and a prevalence of 1.6% and 0.8% for chlamydia 
and gonococcal infections, respectively. However, there 
was an increase of chlamydia infection diagnoses towards 
the end of the decade, which actually corresponded to 
the time point when systematic chlamydia and gono-
coccal infections screening was implemented to all STD 
attendees. If the analysis is restricted to the last 4 years of 
the study (matching the period of systematic screening), 
there is a prevalence of 3% and 0.8% for chlamydia and 
gonococcal infections, respectively. Thus, systematic scre-
ening to all STD attendees has resulted in the diagnosis 
and treatment of an average of 13.7 individuals that 
would otherwise have remained infected. Interestingly, 
the prevalence of gonococcal infection remained stable, 
confirming the symptomatic nature of this infection, pre-
viously reported by Orellana and colleagues14.
Prevalence of asymptomatic infection during the 
study period was 1.2%. It was mainly diagnosed in 
young males presenting other STDs. Fernandes and 
colleagues reported an incidence of 13.5% and 3% of 
asymptomatic chlamydia and gonococcal infections, 
respectively15. However, the study was performed in 
females randomly assigned with more than 4 sexual 
partners. In addition, Huneeus et al reported a 7% pre-
valence of chlamydia infection in young asymptomatic 
females16. CT prevalence in asymptomatic young men 
has been reported around 3% to 5%17-18. The majority of 
our study population, however, was male, highlighting 
that CT prevalence in this gender should not be unde-
restimated, despite reported lower than in females. 
Screening young women for chlamydia infection 
has been shown to be cost-effective, by preventing 
pelvic inflammatory disease, which is a major cause of 
Table 2 - Comparison of socio-demographic characteristics and clinical data between symptomatic and 
asymptomatic STD attendees with genital chlamydia and/or gonococcal infections
Symptomatic infection
(n=28)
Asymptomatic infection
(n=32) P Value*
n % n %
Male 23 82 27 84 NS
Age Median (years) 32 37 NS
Marital status 0,05
Married / Live-in partner 5 18 13 40
Not married / No live-in partner 23 82 19 59
Education level NS
Primary school 14 50 18 56
Highschool/ University 14 50 14 44
Sexual orientation NS
Heterossexual 25 89 26 81
MSM 3 11 6 19
Number of partners in the previous 6 months NS
1 15 54 16 50
More than 1 13 46 16 50
Partner NS
Steady 16 57 17 53
Occasional 12 43 15 47
Other STI 14 50 20 63 0,02
*= χ2 test; STI - Sexual Transmitted Infection; MSM - Men who have Sex with Men; NS= Not significant
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infertility and chronic pelvic pain19. Although screening 
has increased significantly, there remains a proportion 
of women at risk who still lack access to it20, 21. More so, 
screening of young men may be crucial as a strategy to 
prevent chlamydia infection in young women. However, 
evidence to support recommendations of screening in 
men is still scarce.
The economic burden of pelvic inflammatory dise-
ase and infertility has recently drawn a lot of debate. 
In the UK, the cost of treating complications from this 
infection was estimated to be around 50 to 100 million 
pounds per year throughout the last decade of the 
twentieth century22.The average cost of this screening in 
our STD clinic is 108 euros per person. Since oppor-
tunistic screening has been shown to be cost effective 
at infection prevalence between 2% and 6% (10), we 
suggest it is worthy to screen all STD attendees. We 
obtained a 3% prevalence of chlamydia infection in the 
systematic screening throughout the last 4 years of the 
study, and furthermore, the most frequent patient profile 
was: male gender, in the 30ies, single, heterosexual, 
with basic scholarship qualification and with concurrent 
STI(s). Whether chlamydia and gonococcal screening 
should be targeted to this particular patient profile or, 
instead, offered to all sexually active citizens in primary 
care centres can only be assessed in a few years from 
this time. We believe extensive data obtained in this era, 
when PCR testing is no longer an extravagance, will be 
crucial to provide insight into this issue. 
Although European STD Guidelines do not recom-
mend a routine cure test upon successful chlamydia 
and gonococcal infections treatment23, we performed a 
cure test upon 4-6weeks of treatment in all individuals 
both for reassurance and follow up of partner’s notifi-
cation. We did not obtain any positive result following 
treatment.
We acknowledge some limitations in our study. 
Namely, female screenings with cervical swabs as well 
as self-collected vaginal swab are regarded as the two 
most reliable methods for diagnosis of CT infection in 
women. Nonetheless, we believe that urine samples are 
easier and more comfortable for this gender24. Moreo-
ver, Haugland et al25 recently reported that screening 
accuracy is higher when first void urine is used, even 
though the specificity is lower than that obtained with 
cervix samples. 
We also postulate that the observed increase in 
chlamydia infection reflects the systematic screening to 
all STD attendees initiated in 2007. Maintenance of this 
screening strategy will provide more accurate results 
regarding real progress status of infection in society.
CONCLUSIONS
Sexually transmitted infections represent a major 
public health concern in modern societies. Awareness 
of HIV infection contributes to a slight brake in the 
acquisition of STIs such as syphilis and HPV, however 
new sexual habits are contributing to the emergency of 
other diseases. CT and NG infections are distributed 
worldwide, and are associated to the new challenges 
societies are facing. Moreover, both these infections 
can be silent and asymptomatic eventually leading to 
serious consequences in patients. There remains a lot 
of debate concerning the need for universal screening 
in an era invaded by major economic turmoil. However, 
we are confident that screening of both females and 
males is crucial given that these asymptomatic individu-
als represent a vehicle of infection.
Unlike gonococcal infection we found an increase 
of chlamydia infection prevalence when routine scree-
ning was implemented using urine-based nucleic acid 
amplification tests. Screening of STD attendees for CT 
provided the opportunity to identify and treat asympto-
matic Chlamydia infections. 
Nowadays, screening of asymptomatic sexually 
active women for CT infection in some European coun-
tries is available in public health institutions. There is 
no standing recommendation for routine screening of 
males, but STD clinics are important venues in which 
to perform screening for CT in asymptomatic males 
provides the opportunity to identify and treat substantial 
numbers of CT infections.
We expect this study provides new understanding 
concerning status of these emergent bacterial infections 
and insights into prevention strategies.
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